Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk

Michael V. McConnell, Ioannis Vavouranakis, Lily L. Wu, Douglas E. Vaughan, Paul M. Ridker*

*Corresponding author for this work

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

There is substantial epidemiologic data, but limited experimental data, supporting the mortality benefit of low-dose alcohol consumption. A regimen of a single, daily alcoholic beverage was sufficient to increase both high- density lipoprotein (HDL) (4.4%, p = 0.03) and HDL2 (7.7%, p = 0.04) in men and women but did not significantly affect hemostatic markers of cardiovascular risk.

Original languageEnglish (US)
Pages (from-to)1226-1228
Number of pages3
JournalAmerican Journal of Cardiology
Volume80
Issue number9
DOIs
StatePublished - Nov 1 1997

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk'. Together they form a unique fingerprint.

  • Cite this